Effectiveness of a Smart Hearing Aid on Improving Psychosocial Well-being in Elderly
NCT ID: NCT05772949
Last Updated: 2023-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2023-03-07
2023-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary study questions:
1. Can the use of the smart hearing aids reduce loneliness at the end of intervention?
2. Can the use of the smart hearing aids improve quality of life at the end of intervention?
Secondary study questions:
3. Can the use of the smart hearing aids improve the communication quality between caregivers and participants at the end of intervention?
4. How is the satisfaction of the participants with the smart hearing aids?
5. What are the factors leading to the use and non-use of the smart hearing aids?
6. What is the usage time of the smart hearing aids?
Auxiliary study questions:
7. How is the caregiver burden when facilitating the participants to use the smart hearing aids?
8. What are the perceived benefits and acceptability of the smart hearing aids?
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a randomised waitlist controlled trial of comparing the outcome indicators between elders using the smart hearing aids for 6 weeks and elders not using the aids. Elders with hearing impairment from District Elderly Community Service, Haven of Hope Christian Service (HOH DECS) and Day Care Centre for the Elderly, Haven of Hope Christian Service (HOH DE) per the verbal or written medical recommendation by doctor, nurse, physiotherapist, occupational therapist or speech therapist, or currently using hearing aids other than the smart hearing aids in the current study. We will also explore the perceived benefits and acceptability of the smart hearing aids of the participants and caregivers.
This protocol complies with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use - Guideline for Good Clinical Practice (ICH-GCP) and Declaration of Helsinki.
Subjects
Elders with hearing impairment per the verbal or written medical recommendation by doctor, nurse, physiotherapist, occupational therapist or speech therapist, or currently using hearing aids other than the smart hearing aids in the current study from HOH DECS and HOH DE will be recruited for the main analysis.
Procedures
Caregiver training
Identical training sessions will be delivered to caregivers on calibrating and facilitating the participants to use the smart hearing aids.
Participants' recruitment and consent
In the study sites, the staff will invite eligible residents and members to join the trial. Residents scoring above the cutoff for dementia in Montreal Cognitive Assessment (MoCA) and not receiving a medical diagnosis of dementia or other mentally incapacitating disease will be classified as competent in giving consent. For elders scoring below the cutoff in MoCA or receiving a diagnosis of mentally incapacitating disease, we will follow the criteria stated in the Alzheimer Europe Report (2011) to ensure that they are provided chances to give consent. In particular, four criteria will be evaluated, including 1) the person must have sufficient capacity to understand the information, 2) the person is able to retain, use and weight up such information for making a decision, 3) the person will understand the benefit, risk, and convenience, 4) the person must have the ability to communicate the decision. The University of Hong Kong (HKU) research staff and the care staff will first commit them in a causal chat to assess their ability to communicate and understand the dialogues.
If residents / members are competent in giving consent, both residents / members and their family members will be approached for consent. In cases residents are not competent in giving consents, only their family members will be approached for consent. They will then be referred to join a 1-to-1 study introduction session. In this session, HKU research staff and service unit staff will introduce the study to the participant, and invite them to sign a consent form. As a voluntary participation, the participants have the right to withdraw from the study and intervention any time without consequences.
For caregivers, written informed consent will be obtained before doing qualitative interview.
Baseline assessment
After the consent is obtained, the HKU research staff will assist the participants to complete UCLA Loneliness Scale 3-item (UCLA 3-item), World Health Organization Quality of Life Brief Version (WHOQOL-BREF), and Satisfaction with Amplification in Daily Life (SADL) (if they currently use other brands of hearing aids).
Randomization
Participants will be individually randomized to experimental group to use the smart hearing aids from week 1 to week 6, or wait-list control group to follow existing practice (i.e. using no hearing aids or using hearing aids other than the smart hearing aids) from week 1 to week 6 and use the smart hearing aids from week 8 to week 14. A list of random numbers will be generated to create a list of random group allocation (either experimental or wait-list control; allocation ratio 1:1), using the rand function of Excel. The research staff will perform the randomization procedure, by assigning consenting participants who meet all eligibility criteria to the two groups using the list.
Calibration
The caregivers will calibrate the smart hearing aids for the participants in the experimental group at the first day of week 1 and the wait-list control group at week 8 through the designated mobile application. Caregivers will help the participants to choose the amplification level which best suits their needs.
Implementation
Participants in the experimental group can use the smart hearing aids whenever they want during the trial period (i.e. from week 1 to week 6). For participants living in residential setting, caregivers will facilitate them to use the smart hearing aids upon request from the participants or when the caregivers deem the aids beneficial. For participants living in community setting, they will use the smart hearing aids when needed. Their caregivers shall provide assistance in facilitating the participants to use the smart hearing aids. The smart hearing aids do not require any payment from the study participants. They have to return the hearing aids after the study.
Participants in the wait-list control group will continue the current practice (i.e. using conventional hearing aids or no hearing aids) from week 1 to week 8, and will use the smart hearing aids from week 8 to week 14. Caregivers will facilitate the participants to use the smart hearing aids.
Data collection
HKU research staff who is blinded to the group allocation will administer all the questionnaire in assessing the primary outcomes. For the experimental group, the questionnaire assessing the primary outcomes and the secondary outcomes of communication quality and satisfaction with the hearing aids will be administered at baseline and week 6. HKU research staff will conduct questionnaire exploring the secondary outcomes of factors leading to the use and non-use of the smart hearing aids, usage time with caregivers and participants and the auxiliary outcome of caregiver burden at week 1, week 3, and week 6. For wait-list control group, the questionnaire assessing the primary outcomes will be administered at baseline, week 6 and week 14. The questionnaire exploring the secondary and auxiliary outcomes will be conducted by HKU research staff with caregivers and participants at week 8, week 10, and week 14.
In case of events (e.g. COVID-19) that prohibit HKU research staff from conducting assessment on site, assessment will be conducted via online communication apps (e.g. Zoom).
Qualitative interview
To collect feedback towards the smart hearing aids, we will use purposive sampling to select 10 - 15 participants and 4 - 8 caregivers to conduct semi-structured qualitative interviews to collect opinion on their perceived acceptance and benefits on the features of the smart hearing aids. An interview guide with open-ended and iterative questions will be used to probe for more experiences from the interviewees. Each interview will be conducted by a trained research assistant and will last about 30 minutes.
Blinding
Participants and caregivers cannot and will not be blinded to the intervention. Assessor(s) of the follow-up outcomes and the research analysts will not be involved in the recruitment and intervention delivery and will be blinded to the group allocation (single blindness).
Sample size determination
The sample size is estimated by the current number of elders with hearing impairment and / or currently using hearing aids other than the smart hearing aids used in this study in the test sites. In the HOH DECS, 10 elders have been diagnosed hearing impairment and / or are using hearing aids other than the smart hearing aids used in the study. In the HOH DE, 20 have been diagnosed or are using other hearing aids. Therefore, the study will include 30 elders in total.
With reference to Nieman et al. (2022), the between group change difference on UCLA loneliness scale (20-item version) is 2.26 with a pooled variance of 61.9. Using the sample size calculation formula in Noordzij et al. (2010), Type 1 error rate of 5% and power 80%, the number of participant required for each group, 18 participants are required in each group for analysis. Assuming attrition rate of 5%, at least 20 participants need to be recruited.
Data analyses
Main analysis
Linear mixed model analysis will be used to test the interaction between group and time. A partial-eta square will be used to estimate the effect size of the outcome indicators in comparing the intervention group with the wait-list control group. Dependent sample t-test will be used to investigate the within group effects based on the data from both experimental and wait-list control group.
Process evaluations
For the quantitative secondary outcomes, descriptive statistics will be used to show the opinions. For the qualitative secondary outcomes, the content will be analyzed using framework analysis to construct a coherent and logical structure from the classification of many opinions.
Qualitative interview
The interview content will be transcribed verbatim in Chinese for further analysis. We will analyze the qualitative interview transcripts using framework analysis to construct a coherent and logical structure from the classification of many opinions and perceptions on the use of the smart hearing aids. The results will then be discussed and consolidated in the panel meetings with the co-authors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
The experimental group will use the smart hearing aid for 6 weeks.
Experimental group intervention
The caregivers will calibrate the smart hearing aids for the participants in the experimental group at the first day of week 1 through the designated mobile application. Caregivers will help the participants to choose the amplification level which best suits their needs.
Participants in the experimental group can use the smart hearing aids whenever they want during the trial period (i.e. from week 1 to week 6). For participants living in residential setting, caregivers will facilitate them to use the smart hearing aids upon request from the participants or when the caregivers deem the aids beneficial. For participants living in community setting, they will use the smart hearing aids when needed. Their caregivers shall provide assistance in facilitating the participants to use the smart hearing aids. The smart hearing aids do not require any payment from the study participants. They have to return the hearing aids after the study.
Wait-list control group
The wait-list control group will follow existing practice (i.e. using no hearing aids or using hearing aids other than the smart hearing aids) for 6 weeks and then use the smart hearing aids for 6 weeks.
Wait-list control group intervention
The caregivers will calibrate the smart hearing aids for the participants in the wait-list control group at week 8 through the designated mobile application. Caregivers will help the participants to choose the amplification level which best suits their needs.
Participants in the wait-list control group will continue the current practice (i.e. using conventional hearing aids or no hearing aids) from week 1 to week 8, and will use the smart hearing aids from week 8 to week 14. Caregivers will facilitate the participants to use the smart hearing aids.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental group intervention
The caregivers will calibrate the smart hearing aids for the participants in the experimental group at the first day of week 1 through the designated mobile application. Caregivers will help the participants to choose the amplification level which best suits their needs.
Participants in the experimental group can use the smart hearing aids whenever they want during the trial period (i.e. from week 1 to week 6). For participants living in residential setting, caregivers will facilitate them to use the smart hearing aids upon request from the participants or when the caregivers deem the aids beneficial. For participants living in community setting, they will use the smart hearing aids when needed. Their caregivers shall provide assistance in facilitating the participants to use the smart hearing aids. The smart hearing aids do not require any payment from the study participants. They have to return the hearing aids after the study.
Wait-list control group intervention
The caregivers will calibrate the smart hearing aids for the participants in the wait-list control group at week 8 through the designated mobile application. Caregivers will help the participants to choose the amplification level which best suits their needs.
Participants in the wait-list control group will continue the current practice (i.e. using conventional hearing aids or no hearing aids) from week 1 to week 8, and will use the smart hearing aids from week 8 to week 14. Caregivers will facilitate the participants to use the smart hearing aids.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand Chinese
* Responsible for helping the participants to use the smart hearing aids, and
* Able to understand Chinese
Exclusion Criteria
* Unable to use the hearing aids with caregivers' assistance, or
* Ménière's disease, or
* Deafness (i.e. cannot hear speech, even when the speaker is talking loudly next to the better hearing ear)
• Nil
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haven of Hope Hospital
OTHER
The Social Innovation and Entrepreneurship Development Fund, Hong Kong
OTHER
Hong Kong Young Women's Christian Association
OTHER
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Derek Yee-Tak Cheung
Principal Investigator, Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yee Tak Cheung
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haven of Hope Day Care Centre for the Elderly
Hong Kong, , Hong Kong
Haven of Hope District Elderly Community Service
Hong Kong, , Hong Kong
Hong Kong Young Women's Christian Association Wan Wah Care and Attention Home for the Elderly
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cox RM, Alexander GC. Measuring Satisfaction with Amplification in Daily Life: the SADL scale. Ear Hear. 1999 Aug;20(4):306-20. doi: 10.1097/00003446-199908000-00004.
Kam AC. Hearing-aid outcomes in Chinese adults: clinical application and psychometric properties of the Chinese version of the Satisfaction with Amplification in Daily Life questionnaire. Int J Audiol. 2012 Jun;51(6):450-5. doi: 10.3109/14992027.2012.670732. Epub 2012 Apr 26.
Liu T, Lu S, Leung DKY, Sze LCY, Kwok WW, Tang JYM, Luo H, Lum TYS, Wong GHY. Adapting the UCLA 3-item loneliness scale for community-based depressive symptoms screening interview among older Chinese: a cross-sectional study. BMJ Open. 2020 Dec 10;10(12):e041921. doi: 10.1136/bmjopen-2020-041921.
Nieman CL, Betz J, Garcia Morales EE, Suen JJ, Trumbo J, Marrone N, Han HR, Szanton SL, Lin FR. Effect of a Community Health Worker-Delivered Personal Sound Amplification Device on Self-Perceived Communication Function in Older Adults With Hearing Loss: A Randomized Clinical Trial. JAMA. 2022 Dec 20;328(23):2324-2333. doi: 10.1001/jama.2022.21820.
Noordzij M, Tripepi G, Dekker FW, Zoccali C, Tanck MW, Jager KJ. Sample size calculations: basic principles and common pitfalls. Nephrol Dial Transplant. 2010 May;25(5):1388-93. doi: 10.1093/ndt/gfp732. Epub 2010 Jan 12.
Piau A, Campo E, Rumeau P, Vellas B, Nourhashemi F. Aging society and gerontechnology: a solution for an independent living? J Nutr Health Aging. 2014 Jan;18(1):97-112. doi: 10.1007/s12603-013-0356-5.
Russell DW. UCLA Loneliness Scale (Version 3): reliability, validity, and factor structure. J Pers Assess. 1996 Feb;66(1):20-40. doi: 10.1207/s15327752jpa6601_2.
Veiga LR, Merlo AR, Mengue SS. Satisfaction level with hearing aid in the daily life of Army Healthcare System users. Braz J Otorhinolaryngol. 2005 Jan-Feb;71(1):67-73. doi: 10.1016/s1808-8694(15)31287-8. Epub 2006 Jan 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
hearing_aid_protocol_v1
Identifier Type: -
Identifier Source: org_study_id